AffirmHealth Blog

Kratom leaves, https://www.usada.org/substance-profile-kratom/

Kratom: A Primer on the Controversy Surrounding the Opioid Analogue

May 29, 2018 10:00:00 AM by Mario Ramirez, MD posted in Clinician Perspective, DEA, kratom, patient safety

We’ve previously written about the challenges clinicians and patients face as they seek non-opioid alternatives for effective pain management.  One such alternative, Mitragyna speciose, or kratom, has been a focus of increased public discussion lately, but is still a topic that many clinicians are unfamiliar with.  AffirmHealth has developed this short primer to help bring you up to speed so that you can have an informed discussion with your patients.

Read More

The information presented on or through this website is made available solely for general information purposes and is not intended to substitute for professional, medical or legal advice. We do not warrant the accuracy, completeness, or usefulness of this information. Any reliance you place on such information is strictly at your own risk. We disclaim all liability and responsibility arising from any reliance placed on such materials.

Comments